{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:57:21Z","timestamp":1768874241571,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ahj.2015.07.013","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T09:44:08Z","timestamp":1437903848000},"page":"641-651.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial"],"prefix":"10.1016","volume":"170","clinical-trial-number":[{"clinical-trial-number":"nct00856856","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01023789","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01425281","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01751906","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01759290","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01844284","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01923740","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01977534","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02173379","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02229864","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dean J.","family":"Kereiakes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Popma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Samady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Jones-McMeans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai-Fung","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolu","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2015.07.013_bb0005","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.013_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.013_bb0015","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.013_bb0020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.013_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0030","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.013_bb0040","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","article-title":"Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes","volume":"122","author":"Serruys","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.013_bb0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.013_bb0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jcin.2013.11.024","article-title":"Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries","volume":"7","author":"Lane","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2015.07.013_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2015.07.013_bb0060","doi-asserted-by":"crossref","first-page":"E1731","DOI":"10.1016\/S0735-1097(13)61731-3","article-title":"First report of the three year clinical and multi-modality imaging results of the ABSORB trial evaluating the Absorb everolimus eluting bioresorbable vascular scaffold in the treatment of patients with de novo native coronary artery lesions","volume":"61","author":"Serruys","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0065","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2014.09.029","article-title":"OCT assessment of the long-term vascular healing response 5years after everolimus-eluting bioresorbable vascular scaffold","volume":"64","author":"Karanasos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0070","doi-asserted-by":"crossref","first-page":"A1882","DOI":"10.1016\/S0735-1097(14)61885-4","article-title":"ABSORB EXTEND: An interim report on the 24-month clinical outcomes from the first 450 patients enrolled","volume":"63","author":"Carrie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.013_bb0080","doi-asserted-by":"crossref","first-page":"A1707","DOI":"10.1016\/S0735-1097(15)61707-7","article-title":"Differences in the occurence of new or worsening angina between the ABSORB bioresorbable vascular scaffold and XIENCE metallic stent: a post-hoc analysis of the ABSORB II randomized trial","volume":"65","author":"Chevalier","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0085","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.013_bb0090","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.013_bb0095","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","article-title":"Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)","volume":"56","author":"Kereiakes","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:55:24Z","timestamp":1757570124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0002870315004512"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.013","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}